RBC Target UnchangedOur view: Following slightly better than expected Q1/22 results and an in-line Q2/22 and F2022 outlook, our $8 price target is unchanged. Given an impressive array of strategic and tactical initiatives contributing to revenue growth, we continue to believe the shares are notably oversold particularly in an economic/post-COVID-19 recovery scenario through F2023.